Document is current
Any future updates will be listed below
-
Authors
Tsiantoulas, Dimitrios https://orcid.org/0000-0002-7743-3192
Eslami, Mahya
Obermayer, Georg
Clement, Marc
Smeets, Diede
Mayer, Florian J.
Kiss, Máté G. https://orcid.org/0000-0002-9215-8328
Enders, Lennart https://orcid.org/0000-0001-8341-3350
Weißer, Juliane
Göderle, Laura https://orcid.org/0000-0003-1037-3137
Lambert, Jordi
Frommlet, Florian
Mueller, André
Hendrikx, Tim
Ozsvar-Kozma, Maria
Porsch, Florentina https://orcid.org/0000-0002-2633-6632
Willen, Laure
Afonyushkin, Taras
Murphy, Jane E. https://orcid.org/0000-0003-2201-9469
Fogelstrand, Per
Donzé, Olivier
Pasterkamp, Gerard
Hoke, Matthias
Kubicek, Stefan https://orcid.org/0000-0003-0855-8343
Jørgensen, Helle F. https://orcid.org/0000-0002-7909-2977
Danchin, Nicolas
Simon, Tabassome
Scharnagl, Hubert
März, Winfried
Borén, Jan https://orcid.org/0000-0003-0786-8091
Hess, Henry
Mallat, Ziad https://orcid.org/0000-0003-0443-7878
Schneider, Pascal https://orcid.org/0000-0003-0677-9409
Binder, Christoph J. https://orcid.org/0000-0001-8313-7050
- License Information
-
More Information
Article History
Received: 14 June 2019
Accepted: 12 July 2021
First Online: 25 August 2021
Competing interests
: D.T., C.J.B., P.S. and M.E. are named inventors on a patent application (EP20217536.0; pending) to exploit c-APRIL and nc-APRIL for diagnostic and therapeutic purposes in cardiovascular disease that has been filed by the Medical University of Vienna (Austria) and CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences (Austria). O.D. is an employee of Adipogen Life Sciences, which provided some reagents used in this study.
